This company seems to have been delisted
Reason: Filed for bankruptcy
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/biolase-voluntarily-initiates-chapter-11-proceedings-926432
Reason: Filed for bankruptcy
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/biolase-voluntarily-initiates-chapter-11-proceedings-926432
Biolase
BIOL
NZ$0.01977
Share price
0.00%
Change (1 day)
-92.89%
Change (1 year)
Categories
Biolase (BIOL) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : NZ$53.48 Million
According to Biolase 's latest financial reports the company's total liabilities are NZ$53.48 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Biolase - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | NZ$52.44 M | 19.1% |
| 2021-12-31 | NZ$44.03 M | 2.5% |
| 2020-12-31 | NZ$42.95 M | -8.06% |
| 2019-12-31 | NZ$46.72 M | 14.28% |
| 2018-12-31 | NZ$40.88 M | 111.59% |
| 2017-12-31 | NZ$19.32 M | -32.65% |
| 2016-12-31 | NZ$28.69 M | 13.35% |
| 2015-12-31 | NZ$25.31 M | 14.34% |
| 2014-12-31 | NZ$22.13 M | -19.34% |
| 2013-12-31 | NZ$27.44 M | 11.9% |
| 2012-12-31 | NZ$24.52 M | 11.06% |
| 2011-12-31 | NZ$22.08 M | -19.6% |
| 2010-12-31 | NZ$27.47 M | 40.04% |
| 2009-12-31 | NZ$19.61 M | -56.75% |
| 2008-12-31 | NZ$45.35 M | 24.88% |
| 2007-12-31 | NZ$36.31 M | -3.86% |
| 2006-12-31 | NZ$37.77 M | 8.32% |
| 2005-12-31 | NZ$34.87 M | 0.46% |
| 2004-12-31 | NZ$34.71 M | 68.41% |
| 2003-12-31 | NZ$20.61 M | -16.27% |
| 2002-12-31 | NZ$24.61 M | 70.87% |
| 2001-12-31 | NZ$14.4 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Align Technology
ALGN | NZ$3.80 B | 7,010.32% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | NZ$6.65 B | 12,343.02% | 🇺🇸 USA |